Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Experian ( (GB:EXPN) ) has shared an announcement.
Experian plc has announced the total number of voting rights as of 31 October 2025, which stands at 917,626,027. This figure is crucial for shareholders to determine their interest or any changes in their interest in the company’s shares, in compliance with the FCA’s Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:EXPN) stock is a Sell with a £3050.00 price target. To see the full list of analyst forecasts on Experian stock, see the GB:EXPN Stock Forecast page.
Spark’s Take on GB:EXPN Stock
According to Spark, TipRanks’ AI Analyst, GB:EXPN is a Neutral.
Experian’s overall stock score is driven primarily by its strong financial performance, which highlights robust revenue growth and efficient cash flow management. However, the technical analysis indicates short-term bearish momentum, and the high P/E ratio suggests a premium valuation, which could limit upside potential. The absence of earnings call data and corporate events means these factors do not influence the score.
To see Spark’s full report on GB:EXPN stock, click here.
More about Experian
Experian is a global data and technology company that provides services across various industries, including financial services, healthcare, automotive, agrifinance, and insurance. The company specializes in redefining lending practices, preventing fraud, simplifying healthcare, delivering digital marketing solutions, and offering insights into the automotive market through its data, analytics, and software. Experian is listed on the London Stock Exchange and is part of the FTSE 100 Index, with its headquarters in Dublin, Ireland.
Average Trading Volume: 1,973,826
Technical Sentiment Signal: Buy
Current Market Cap: £32.48B
For detailed information about EXPN stock, go to TipRanks’ Stock Analysis page.